Concurrent Benzodiazepine, Opioid Use Up Significantly

Share this content:
Concurrent Benzodiazepine, Opioid Use Up Significantly
Concurrent Benzodiazepine, Opioid Use Up Significantly

WEDNESDAY, March 15, 2017 (HealthDay News) -- From 2001 to 2013, concurrent benzodiazepine/opioid use significantly increased in privately-insured patients in the United States, according to a report published online March 14 in The BMJ.

Eric Sun, M.D., Ph.D., an assistant professor of anesthesiology, perioperative, and pain medicine at Stanford University in California, and colleagues collected data on 315,428 privately-insured patients, aged 18 to 64, who were prescribed an opioid between 2001 and 2013.

The researchers found that in 2001, 9 percent of those patients also had prescriptions for benzodiazepines. By 2013, that had increased to 17 percent. Compared with patients only prescribed opioids, use of both opioids and benzodiazepines was associated with an increased risk of an emergency department visit or inpatient admission for opioid overdose among all opioid users (adjusted odds ratio, 2.14). For intermittent opioid users and chronic opioid users, the adjusted odds ratios for emergency department visit or inpatient admission for opioid overdose were 1.42 and 1.81, respectively.

"Elimination of the concurrent use of benzodiazepines and opioids could reduce the population risk of an emergency room visit or inpatient admission for opioid overdose by 15 percent," the authors write. "From a clinical perspective, providers should exercise caution in prescribing opioids for patients who are already using benzodiazepines (or vice versa), even in a non-chronic setting."

Abstract/Full Text
Editorial

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »